UPDATED May 26, 2022
Stocks with a return on equity of over 30% and a debt to equity ratio below 1.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
2222Saudi Arabian Oil | ر.س40.70 | 2.4% | 27.0% | ر.س9.0t | ر.س39.10 | PS19.5x | E-4.9% | 3.1% | Energy | ||
MSFTMicrosoft | US$265.90 | 5.0% | 6.7% | US$2.0t | US$361.47 | PS27.4x | E11.6% | 0.9% | Software | ||
FBMeta Platforms | US$191.63 | 0.2% | -42.4% | US$518.6b | US$287.32 | PS13.9x | E13.8% | n/a | Media | ||
NVDANVIDIA | US$178.51 | 4.2% | 15.3% | US$447.0b | US$309.59 | PS45.8x | E14.4% | 0.09% | Semiconductors | ||
VVisa | US$208.55 | 5.7% | -8.1% | US$434.4b | US$265.30 | PS32.3x | E12.1% | 0.7% | Software | ||
PGProcter & Gamble | US$146.48 | 3.4% | 8.5% | US$351.4b | US$166.59 | PS24.6x | E5.3% | 2.4% | Household | ||
NESNNestlé | CHF116.58 | 3.0% | 4.9% | CHF321.7b | CHF128.35 | PS19x | E-5.2% | 2.4% | Food, Beverage & Tobacco | ||
PFEPfizer | US$53.99 | 6.6% | 39.7% | US$302.9b | US$57.66 | PS11.9x | E-17.1% | 3.0% | Pharmaceuticals & Biotech | ||
MRKMerck | US$92.31 | 0.2% | 21.6% | US$233.4b | US$96.04 | PS16.8x | E13.0% | 3.0% | Pharmaceuticals & Biotech | ||
NVSNovartis | US$91.26 | 2.9% | 3.1% | US$198.2b | US$98.17 | PS8.2x | E1.5% | 3.4% | Pharmaceuticals & Biotech | ||
NOVNNovartis | CHF87.12 | 0.5% | 9.4% | CHF189.2b | CHF91.51 | PS8.2x | E1.7% | n/a | Pharmaceuticals & Biotech | ||
ADBEAdobe | US$408.60 | 3.6% | -18.0% | US$193.1b | US$559.37 | PS40x | E16.2% | n/a | Software | ||
ACNAccenture | US$291.55 | 6.6% | 4.1% | US$184.7b | US$396.03 | PS28.9x | E10.2% | 1.3% | Software | ||
NKENIKE | US$112.94 | 6.1% | -17.3% | US$177.7b | US$162.94 | PS29.1x | E14.7% | 1.1% | Consumer Durables | ||
BHPBHP Group | AU$43.67 | -7.4% | -9.3% | AU$221.0b | AU$49.89 | PS10x | E-18.6% | 11.3% | Materials | ||
TCSTata Consultancy Services | ₹3,261.30 | -1.0% | 3.7% | ₹11.9t | ₹3,939.02 | PS31.1x | E10.2% | 1.3% | Software | ||
PRXProsus | €45.87 | 0.9% | -45.9% | €116.9b | €89.13 | PS6.2x | E-45.7% | 0.3% | Retail | ||
RIORio Tinto Group | UK£57.02 | 4.6% | -6.0% | UK£95.0b | UK£63.48 | PS5.5x | E-20.8% | 12.9% | Materials | ||
ELEstée Lauder Companies | US$240.40 | 2.1% | -20.8% | US$85.9b | US$305.58 | PS25.6x | E10.8% | 1.0% | Household | ||
REGNRegeneron Pharmaceuticals | US$683.44 | 4.0% | 38.0% | US$73.6b | US$691.67 | PS9.3x | E-3.2% | n/a | Pharmaceuticals & Biotech | ||
NOCNorthrop Grumman | US$467.43 | 4.2% | 26.2% | US$72.7b | US$481.79 | PS12.6x | E4.7% | 1.3% | Capital Goods | ||
9633Nongfu Spring | HK$42.75 | 2.0% | -4.4% | HK$480.8b | HK$46.07 | PS57.6x | E14.3% | 1.2% | Food, Beverage & Tobacco | ||
ABBNABB | CHF29.36 | 2.6% | -4.3% | CHF56.6b | CHF34.36 | PS12.6x | E7.8% | 2.7% | Capital Goods | ||
AALAnglo American | UK£38.03 | 7.9% | 21.3% | UK£46.2b | UK£39.95 | PS6.8x | E-15.3% | 6.0% | Materials |